Provided by Tiger Fintech (Singapore) Pte. Ltd.

Legend Biotech

34.03
-1.2300-3.49%
Post-market: 34.470.4400+1.29%19:07 EDT
Volume:1.14M
Turnover:39.35M
Market Cap:6.24B
PE:-17.76
High:35.40
Open:34.58
Low:33.95
Close:35.26
Loading ...

Legend Biotech Price Target Maintained With a $86.00/Share by RBC Capital

Dow Jones
·
29 Oct 2024

RBC Capital Remains a Buy on Legend Biotech (LEGN)

TIPRANKS
·
29 Oct 2024

Legend Biotech participates in a conference call with JPMorgan

TIPRANKS
·
28 Oct 2024

Analysts Have Conflicting Sentiments on These Healthcare Companies: Legend Biotech (LEGN), Molina Healthcare (MOH) and Edwards Lifesciences (EW)

TIPRANKS
·
25 Oct 2024

Legend Biotech Shares up 2.4% After Key Shareholder to Deconsolidate Co

THOMSON REUTERS
·
22 Oct 2024

Legend Biotech Faces Financial Restructuring Amid Voting Changes

TIPRANKS
·
22 Oct 2024

BUZZ-Legend Biotech gains as key shareholder to deconsolidate co

Reuters
·
22 Oct 2024

Legend Biotech Shares Jump 8.3% Premarket After Key Shareholder Resolves to Deconsolidate Co and Its Units

THOMSON REUTERS
·
22 Oct 2024

BUZZ-Genscript jumps on expected gains from Legend Biotech deconsolidation

Reuters
·
22 Oct 2024

Genscript Biotech Announces Deconsolidation of Legend Biotech

TIPRANKS
·
22 Oct 2024

Legend Biotech’s AGM Highlights Shareholder Confidence

TIPRANKS
·
22 Oct 2024

Top small-cap stock picks from Morgan Stanley following the group's upgrade to neutral

seekingalpha
·
22 Oct 2024

Strategic Growth and Promising Prospects Drive Buy Rating for Legend Biotech

TIPRANKS
·
21 Oct 2024

Is Legend Biotech Corporation (LEGN) the Most Promising Biotech Stock According to Hedge Funds?

Insider Monkey
·
17 Oct 2024

BUZZ-Arcellx rises as Guggenheim lifts PT, reiterates 'buy' rating

Reuters
·
17 Oct 2024

Strong Q3 Performance and Upcoming Catalysts Drive Buy Rating for Legend Biotech

TIPRANKS
·
16 Oct 2024